The Global X Founder-Run Companies ETF (BOSS) seeks to generate alpha over the broad market by offering exposure to primarily U.S. mid- and large-cap companies who are led by their founder(s).
The Global X Founder-Run Companies ETF (BOSS) seeks to generate alpha over the broad market by offering exposure to primarily U.S. mid- and large-cap companies who are led by their founder(s).
The Global X Founder-Run Companies ETF (BOSS) seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive U.S. Founder-Run Companies Index.
BOSS provides exposure primarily to U.S. mid- and large-cap companies led by a CEO who founded the firm.
Founders tend to have significant personal wealth tied to the companies they lead, and thus often focus on long-term value creation through innovation and entrepreneurialism.
BOSS allows investors to buy and sell a broad basket of founder-run U.S. equities, with the tax efficiency of an ETF.
| Ticker | BOSS |
| Inception Date | 2/13/17 |
| CUSIP | 37954Y681 |
| ISIN | US37954Y6813 |
| Bloomberg Index Ticker | SOLUSFRC |
| Primary Exchange | Cboe |
| Net Assets | $3,798,756 |
| NAV | $18.99 |
| Shares Outstanding | 200,000 |
| Total Expense Ratio | 0.45% |
| 30-Day SEC Yield | 0.53% |
| Distribution Frequency | Semi-Annually |
| NAV | Price | ||||
|---|---|---|---|---|---|
| Net Asset Value | $18.99 | Closing Price | $18.98 | ||
| Daily Change | $0.20 | 1.07% | Daily Change | $0.20 | 1.04% |
Cumulative %Data as of month end (9/30/19) |
Fund NAV | Closing Price | Index |
|---|---|---|---|
| 1 Month | -2.45% | -2.40% | -2.43% |
| 3 Months | -5.64% | -5.55% | -5.53% |
| 6 Months | -5.47% | -5.52% | -5.23% |
| Since Inception | 28.96% | 28.89% | 31.07% |
Avg Annualized %Data as of month end (9/30/19) |
Fund NAV | Closing Price | Index |
|---|---|---|---|
| 1 Year | -7.42% | -8.44% | -6.91% |
| Since Inception | 10.16% | 10.14% | 10.85% |
Avg Annualized %Data as of quarter end (9/30/19) |
Fund NAV | Closing Price | Index |
|---|---|---|---|
| 1 Year | -7.42% | -8.44% | -6.91% |
| Since Inception | 10.16% | 10.14% | 10.85% |
Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized Return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.
| Return on Equity | 11.40% | |
| Average Market Cap | $36,947.00 M | |
| 2018 | 2019 | |
| Price-to-earnings | 38.32 | 30.32 |
| Price-to-book value | 3.60 | 3.34 |
Source: AltaVista Research, LLC
| Versus | Beta |
|---|---|
| S&P 500 | 1.21 |
| MSCI EAFE | 1.04 |
| MSCI Emg. Mkts | 0.72 |
| Standard Deviation | 17.60% |
Source: AltaVista Research, LLC
| Net Assets % | Name | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|
| 2.24 | ROKU INC | 133.03 | 641 | 85,272.23 |
| 1.57 | SEATTLE GENETICS INC | 100.89 | 593 | 59,827.77 |
| 1.49 | RINGCENTRAL INC-CLASS A | 160.50 | 352 | 56,496.00 |
| 1.43 | SNAP INC - A | 14.58 | 3,726 | 54,325.08 |
| 1.39 | MARKETAXESS HOLDINGS INC | 353.40 | 149 | 52,656.60 |
| 1.34 | NEUROCRINE BIOSC | 97.27 | 525 | 51,066.75 |
| 1.29 | COSTAR GROUP INC | 589.21 | 83 | 48,904.43 |
| 1.27 | SKECHERS USA INC-CL A | 37.50 | 1,288 | 48,300.00 |
| 1.25 | AKAMAI TECHNOLOGIES INC | 91.89 | 515 | 47,323.35 |
| 1.24 | MEDICAL PROPERTI | 20.29 | 2,325 | 47,174.25 |
| Holdings are subject to change. Cash, where shown, includes other assets and liabilities, such as payables and receivables. | ||||
Investing involves risk, including the possible loss of principal. The investable universe of companies in which the Fund may invest may be limited. BOSS is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Global X NAVs are calculated using prices as of 4:00 PM Eastern Time. The closing price is the Mid-Point between the Bid and Ask price as of the close of exchange. Closing price returns do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index. Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in shares, the NAV of the Fund is used to calculate market returns.
High short-term performance of the Fund is unusual and investors should not expect such performance to be repeated.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.
888-493-8631
Leave us a note